National Healthcare Properties, Inc. (NHP) · Sep 28, 2026 · Disposition
$531M disposition — 40 outpatient facilities for approximately $531 million; expected Q4 2026 close
National Healthcare Properties advances a $531 million outpatient medical property sale after buyer termination rights expire, but closing remains pending.
National Healthcare Properties is a healthcare REIT balancing senior housing with outpatient medical facilities, while a broader 2026 asset-sale program is reducing its outpatient exposure and potentially redirecting capital toward senior housing. As of June 30, 2026, it reported 130 outpatient medical facilities alongside 39 senior housing communities.
The transaction has cleared a meaningful execution hurdle, but it is not closed. Certain purchaser termination rights expired on September 25, reducing one source of deal risk, while the filing still says closing is subject to customary conditions in the fourth quarter. 〔0〕 〔1〕
This extends a known outpatient-property sell-down rather than creating a new strategic direction. NHP had already announced an 86-facility outpatient sale and closed a first tranche of 30 properties for approximately $79 million in net cash proceeds on September 10, 2026. The new 40-property agreement adds substantial monetization, but also further shrinks the outpatient platform that provides relatively stable healthcare real-estate income.
The $531 million headline is useful, but the filing does not show the proceeds’ end use or transaction economics. It gives the gross sale price before expenses, prorations and other adjustments, but provides no valuation comparison, debt payoff detail or expected earnings impact.
Bottom line: This is a moderately important progress update on NHP’s portfolio reshaping, not a completed sale. It improves transaction certainty, but the business impact remains two-sided until closing and proceeds deployment are clearer.
Q4 2026 closing of the 40-facility sale
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!